巨细胞在动脉样硬化中的作用:病理生理机制和治疗考虑
Panagiotis Theofilis1, Evangelos Oikonomou2, Konstantinos Tsioufis1
1First Department of Cardiology, "Hippokration" General Hospital, University of Athens Medical School, 11527 Athens, Greece.
International journal of molecular sciences
|June 10, 2023
概括
巨细胞是动脉样硬化的关键. 准它们的M2极化和自显示出治疗这种主要心血管疾病的前景,巨受体和膜涂层载体提供了新的治疗途径.
科学领域:
- 心血管研究研究心血管研究
- 免疫学 免疫学 免疫学
- 病理生理学 病理生理学
背景情况:
- 动脉样硬化疾病仍然是全球发病率和死亡率的主要原因.
- 巨细胞在动脉样硬化级联中发挥着至关重要的作用,尽管它们的精确功能需要进一步阐明.
- 了解巨细胞亚型及其对疾病进展或回归的独特贡献至关重要.
研究的目的:
- 探索巨细胞在动脉样硬化中的多方面的作用.
- 突出针对巨细胞两极化和自的潜在治疗策略.
- 审查涉及巨受体和膜涂层载体用于动脉样硬化治疗的新兴方法.
主要方法:
- 关于动脉样硬化的巨细胞生物学现有文献的综述.
- 对研究M2极化和动脉保护中的自的研究进行分析.
- 对作为药物点的巨细胞受体实验数据的检查.
- 对巨细胞膜覆盖载体的研究评估.
主要成果:
- 在动脉样硬化中发现了组织居民和单细胞衍生的巨细胞的不同功能.
- M2极化和巨细胞自被证明是动脉保护机制.
- 巨细胞受体显示出作为可行的药物点的潜力.
- 巨细胞膜覆盖的载体表现出有希望的治疗效果.
结论:
- 向巨细胞M2极化和自是一种有前途的治疗策略,用于动脉样硬化疾病.
- 巨受体和覆盖膜的载体代表了未来心血管医学药物开发的创新途径.
相关概念视频
Inflammation
54.0K
Overview
54.0K
Atherosclerosis I: Introduction
13
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
13
Atherosclerosis III: Management
15
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
15
Coronary Artery Disease II: Pathophysiology
15
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
15
Coronary Artery Disease I: Introduction
33
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
33
Atherosclerosis IV: Nursing Management
26
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
26


